NEW YORK, May 31 (GenomeWeb News) - Agilent Technologies will market and sell ExonHit's line of splice variant arrays as commercial products worldwide, the companies said today.
Agilent will now offer nine different ExonHit human and mouse SpliceArrays through its offices globally.
ExonHit's SpliceArray technology "also complements [Agilent's existing] portfolio of microarray-based research tools," Fran Dinuzzo, Agilent's vice president and general manager of integrated biology solutions, said in a statement.
Agilent originally agreed to distribute ExonHit's arrays last August. The arrays were initially offered only through a service when they were launched by ExonHit in February 2005.
Financial details of the new alliance were not discussed.